[1]
“LIPID HOMEOSTASIS PECULARITIES IN ISCHEMIC HEART DISEASE PATIENTS WITH HEART FAILURE SYMPTOMS, DIABETES MELLITUS 2 TYPE AND METABOLIC SYNDROME DEPENDING ON MEDICATION PECULIARITIES”, J. V. N. Karazin Khark. Nat. Univ., Ser. Med., no. 15, pp. 79–84, Jul. 2015, Accessed: Oct. 25, 2026. Available: https://periodicals.karazin.ua/medicine/article/view/7013